TY - JOUR
T1 - Perioperative management of special populations
T2 - Immunocompromised host (cancer, HIV, transplantation)
AU - Desai, Dev M.
AU - Kuo, Paul C.
PY - 2005/12/1
Y1 - 2005/12/1
N2 - The perioperative management of immunocompromised patients can be successfully undertaken without increased morbidity or mortality through vigilant attention to detail and a basic understanding of the pharmacology and toxic profile of the drugs most commonly used in the management of this patient population. When complications occur, early recognition of these problems and their causes, especially consideration of drug-mediated side effects, are imperative to minimize the potential morbidity.
AB - The perioperative management of immunocompromised patients can be successfully undertaken without increased morbidity or mortality through vigilant attention to detail and a basic understanding of the pharmacology and toxic profile of the drugs most commonly used in the management of this patient population. When complications occur, early recognition of these problems and their causes, especially consideration of drug-mediated side effects, are imperative to minimize the potential morbidity.
UR - http://www.scopus.com/inward/record.url?scp=28544432172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28544432172&partnerID=8YFLogxK
U2 - 10.1016/j.suc.2005.09.010
DO - 10.1016/j.suc.2005.09.010
M3 - Review article
C2 - 16326207
AN - SCOPUS:28544432172
VL - 85
SP - 1267
EP - 1282
JO - Surgical Clinics of North America
JF - Surgical Clinics of North America
SN - 0039-6109
IS - 6
ER -